Celanese Corporation

CE • Chemicals - Specialty

$44.67

▼ -0.53 (-1.17%)

Current price

EarningsLatest report: Mar 31, 2026

BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.

Market Cap

$4.91B

Growth

0.6%

Cash Flow

5/5

Trend

Stable

Evidence

Positive free cash flow · 7.33Consistent free cash flow · 5/5Healthy liquidity · 1.55High debt level · 3.19Negative growth trend

Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 5, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$44.67

Change-1.17%

Shares Out110.00M

Market Cap$4.91B

Enterprise Value$15.71B

52W Range35.13 - 70.70

Beta0.74

P/E-4.49

P/S0.52

P/B1.21

P/FCF5.60

EV/Sales1.66

Price$44.67

Change-1.17%

Shares Out110.00M

Market Cap$4.91B

Enterprise Value$15.71B

52W Range35.13 - 70.70

Beta0.74

P/E-4.49

P/S0.52

P/B1.21

P/FCF5.60

EV/Sales1.66

EV/EBITDA47.46

EV/FCF17.89

Earnings Yield-22.28%

FCF Yield17.87%

Dividend Yield0.27%

Gross Margin18.77%

Oper. Margin8.04%

Profit Margin-12.21%

Debt/Eq3.19

Current Ratio1.55

Quick Ratio0.94

Revenue 5Y0.56%

FCF 5Y1.30%

Target$60.40

Target Upside35.21%

Target Median$60.00

Target Range50.00 - 75.00

Volume1.10M

Avg Volume2.01M

EPS Surprise-0.03

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

32/100

Financial Strength

Debt, cash, stability

45/100

Growth Potential

Revenue and expansion

36/100

Price Attractiveness

Cheap or expensive today

76/100

Why this score▼

Positive free cash flow · 7.33Consistent free cash flow · 5/5Healthy liquidity · 1.55High debt level · 3.19Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment

Based on 37 analyst votes · 2026-09-05

59/100

Neutral

Bullish

Hold

Bearish

Price Target

2026-06-26

Low

$50.00

Mean

$65.60

Median

$63.50

High

$86.00

Company Overview

IPO: 1/21/2005

Industry: Chemicals - Specialty

P/B i: 1.21

Debt / Equity i: 3.19

Operating Margin: 8.04%

Net Margin: -12.21%

ROE i: -

ROIC: -

Financial Health

Score9 / 20

Debt / Equity: 3.19

Current Ratio: 1.55

Quick Ratio: 0.94

Status: Moderate

Warnings

High debt level

Insider Transactions

Recent executive and insider activity

GALANTE EDWARD G

Transaction: 05/11/2026

BUY

Change

—

Price

Not reported

Filing

05/13/2026

Type

BUY

GALANTE EDWARD G

Transaction: 05/11/2026

BUY

Change

+4,676

Price

Not reported

Filing

05/13/2026

Type

BUY

Kuehn Christopher J

Transaction: 05/11/2026

BUY

Change

+2,975

Price

Not reported

Filing

05/13/2026

Type

BUY

Insider	Type	Change	Price	Transaction	Filing
GALANTE EDWARD G	BUY	—	Not reported	05/11/2026	05/13/2026
GALANTE EDWARD G	BUY	+4,676	Not reported	05/11/2026	05/13/2026
Kuehn Christopher J	BUY	+2,975	Not reported	05/11/2026	05/13/2026
Hill Kathryn	BUY	—	Not reported	05/11/2026	05/13/2026
Hill Kathryn	BUY	+2,975	Not reported	05/11/2026	05/13/2026
Rucker Kim K.W.	BUY	+2,975	Not reported	05/11/2026	05/13/2026
Rucker Kim K.W.	BUY	—	Not reported	05/11/2026	05/13/2026
Kissire Deborah J.	BUY	+2,975	Not reported	05/11/2026	05/13/2026
Kissire Deborah J.	BUY	—	Not reported	05/11/2026	05/13/2026
MOORTHY GANESH	BUY	+2,975	Not reported	05/11/2026	05/13/2026
Koenig Michael	BUY	+2,975	Not reported	05/11/2026	05/13/2026
Noonan Anne P	BUY	+2,975	Not reported	05/11/2026	05/13/2026
Chinn Bruce E.	BUY	+2,975	Not reported	05/11/2026	05/13/2026
Kuehn Christopher J	SELL	-3,376	Not reported	05/09/2026	05/13/2026
Kuehn Christopher J	BUY	+3,376	Not reported	05/09/2026	05/13/2026
Rucker Kim K.W.	SELL	-3,376	Not reported	05/09/2026	05/13/2026
Rucker Kim K.W.	BUY	+3,376	Not reported	05/09/2026	05/13/2026
Kissire Deborah J.	SELL	-3,376	Not reported	05/09/2026	05/13/2026
Kissire Deborah J.	BUY	+3,376	Not reported	05/09/2026	05/13/2026
Koenig Michael	SELL	-1,013	$57.51	05/09/2026	05/13/2026

About the Company

Celanese Corporation

Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular weight polyethylene, and thermoplastic elastomers, polyesters, and vulcanizates for use in appliance, automotive, construction, consumer apparel, consumer electronics, electrical, energy storage, filtration equipment, industrial, medical, and telecommunication applications. It also provides acetic acid and anhydride, acetate flakes and tows, butyl acetates, emulsion polymers, ethyl acetates, ethylene vinyl acetate resins and compounds, formaldehydes, redispersible powders, and vinyl acetate monomers for use in adhesives, automotive parts, coatings, consumer goods, external thermal insulation composite systems, films, filtration, flexible packaging, food and beverage, food packaging, inks, lamination, lubricants, paints, paper finishing, pharmaceuticals, plasticizers, plasters and renders, solvents, textiles, and tiling applications. The company offers its products under the Amcel, AOPlus, Ateva, Avicor, Celanese, Celanex, Celanyl, Celcon, Celstran, Celvolit, Clarifoil, Crastin, Dur-O-Set, Dytron, ECOMID, EcoVAE, Elotex, Factor, Flexbond, Forprene, FRIANYL, Fortron, Geolast, GHR, GUR, Hostaform, Hytrel, Laprene, Melinex, MetaLX, Mowilith, MT, Mylar, NILAMID, Nylfor, OmniLon, Pibifor, Pibiter, Polifor, Resyn, Rynite, Santoprene, SlideX, Sofprene, Sofpur, Talcoprene, Tarnoform, Tecnoprene, TufCOR, Tynex, Vamac, VAntage, Vectra, Vinac, Vinamul, VitalDose, Zenite, and Zytel brands. It sells its products directly to customers and through distributors; and original equipment manufacturers and suppliers. Celanese Corporation was founded in 1912 and is headquartered in Irving, Texas.

Source - link

Peers

ASH BCPC CBT FUL HWKN ORLA SSL SSRM SXT TMC

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Jupiter Topco LLC Purchases New Position in Celanese Corporation $CE

Jupiter Topco LLC acquired a new position in Celanese Corporation (NYSE: CE) during the quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 49,309 shares of the basic materials company's stock, valued at approximately $2,266,000. Other institutional investors also

Defense World

Why Is Celanese (CE) Up 8.2% Since Last Earnings Report?

Celanese (CE) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research

Celanese to Sell Additional 19% of Nutrinova Stake to Mitsui for $152M

CE will sell another 19% of Nutrinova to Mitsui for $152M, using proceeds to cut net debt while retaining an 11% stake in the food venture.

Zacks Investment Research

Celanese to Sell Additional Shares of Nutrinova Joint Venture to Mitsui & Co., Ltd.

DALLAS & FRANKFURT--(BUSINESS WIRE)---- $CE--Celanese to Sell Additional Shares of Nutrinova Joint Venture to Mitsui & Co., Ltd.

Business Wire

Bank of New York Mellon Corp Takes $31.26 Million Position in Celanese Corporation $CE

Bank of New York Mellon Corp bought a new stake in shares of Celanese Corporation (NYSE: CE) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 679,580 shares of the basic materials company's stock, valued at approximately $31,261,000.

Defense World

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-05-05	0.88	0.85	-0.03
2026-02-17	0.89	0.67	-0.22
2025-11-06	1.27	1.34	0.07
2025-08-11	1.38	1.44	0.06
2025-05-05	0.37	0.57	0.2
2025-02-18	1.25	1.45	0.2
2024-11-04	2.85	2.44	-0.41
2024-08-01	2.72	2.38	-0.34
2024-05-08	1.91	2.08	0.17
2024-02-20	2.29	2.24	-0.05
2023-11-06	2.2	2.5	0.3
2023-08-07	2.48	2.17	-0.31